S Slavin, E Naparstek, A Nagler, Y Kapelushnik, A Ackerstein, R Or; Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT [letter; comment]. Blood 1996; 87 (9): 4011–4013. doi: https://doi.org/10.1182/blood.V87.9.4011.bloodjournal8794011
![First page of Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT [letter; comment]](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/87/9/10.1182_blood.v87.9.4011.bloodjournal8794011/2/4011.pdf.gif?Expires=1748597991&Signature=vXUbpDsHfvxD5QgWTYp14HTQLVlg-ci8HJ-KW--GxuhihbU7Muoyz0gkkJMnJ3njDPa~450bC191Po-s8JypKYbJnQVPcfugMepisMSF8VOpH0Ztu9UXVpqKtFXSBmBkMoSPJJgn6Bh90VTwkEq04f6sHvTS00RSSEaf6fvUq0oBndZzgYyLl7ZLF2DlfO4S2pogMwtVVFyrluQ-vizVOlHYPINZ~Qp-xByHynugfW3UrZScf4yn2u1PcT1zrdj3wopt92SENGJdJyBVrMYM38ilD1IMo4LgpBcQq02ELizuVPgMT39JGQ4oW1cloxZfef16FoKJk-K0dWdmjVFFLg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
